Biotechnology
The Biotechnology industry has a total of 585 stocks, with a combined market cap of $1.31 trillion and total revenue of $116.09 billion.
Market Cap
1.31T
Revenue
116.09B
Profits
-38.86B
PE Ratio
n/a
Profit Margin
-33.48%
Dividend Yield
0.04%
586 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 130.64B | 0.17% | 898,508 | 12.59B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 78.04B | -1.48% | 443,989 | 15.53B |
| 3 | ARGX | argenx SE | 61.97B | 0.04% | 181,875 | 5.32B |
| 4 | MRNA | Moderna, Inc. | 57.48B | 5.38% | 15,444,899 | 2.23B |
| 5 | RVMD | Revolution Medicines, Inc. | 43.68B | 0.21% | 1,378,671 | - |
| 6 | ONC | BeOne Medicines AG | 39.40B | 1.38% | 311,025 | 6.13B |
| 7 | RPRX | Royalty Pharma plc | 33.70B | -0.24% | 2,596,068 | 2.54B |
| 8 | ALNY | Alnylam Pharmaceuticals, Inc. | 33.28B | 0.47% | 1,177,423 | 4.80B |
| 9 | ROIV | Roivant Sciences Ltd. | 29.49B | -0.29% | 5,963,910 | 7.53M |
| 10 | INSM | Insmed Incorporated | 28.26B | 1.67% | 1,698,268 | 1.14B |
| 11 | INCY | Incyte Corporation | 24.62B | -1.47% | 1,425,198 | 5.82B |
| 12 | BNTX | BioNTech SE | 24.30B | 0.34% | 1,176,607 | 3.03B |
| 13 | GMAB | Genmab A/S | 19.41B | 0.74% | 1,394,020 | 4.13B |
| 14 | ASND | Ascendis Pharma A/S | 17.31B | 0.87% | 443,504 | 1.20B |
| 15 | JAZZ | Jazz Pharmaceuticals plc | 15.96B | 2.21% | 422,911 | 4.60B |
| 16 | BBIO | BridgeBio Pharma, Inc. | 14.16B | -0.08% | 1,766,611 | 713.07M |
| 17 | SMMT | Summit Therapeutics Inc. | 14.00B | 3.24% | 4,278,037 | - |
| 18 | EXEL | Exelixis, Inc. | 13.91B | -2.28% | 2,916,863 | 2.44B |
| 19 | BMRN | BioMarin Pharmaceutical Inc. | 12.71B | 0.26% | 1,604,794 | 3.41B |
| 20 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.35B | 0.24% | 47,118 | 1.28B |
| 21 | CORT | Corcept Therapeutics Incorporated | 12.19B | -1.85% | 1,299,469 | 830.81M |
| 22 | HALO | Halozyme Therapeutics, Inc. | 12.17B | 0.19% | 861,839 | 1.66B |
| 23 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.70B | 0.11% | 1,335,811 | 669.50M |
| 24 | AXSM | Axsome Therapeutics, Inc. | 11.56B | 4.56% | 1,228,400 | 776.57M |
| 25 | TECH | Bio-Techne Corporation | 11.31B | 0.06% | 2,723,696 | 1.22B |
| 26 | KRYS | Krystal Biotech, Inc. | 10.27B | 0.42% | 206,324 | 440.48M |
| 27 | CYTK | Cytokinetics, Incorporated | 10.26B | 0.20% | 1,721,518 | 67.67M |
| 28 | ABVX | ABIVAX Société Anonyme | 10.25B | 2.32% | 893,445 | 5.67M |
| 29 | PTGX | Protagonist Therapeutics, Inc. | 9.59B | 2.08% | 478,038 | 281.99M |
| 30 | KYMR | Kymera Therapeutics, Inc. | 9.56B | -0.45% | 66,567 | 105.00M |
| 31 | PRAX | Praxis Precision Medicines, Inc. | 9.34B | -1.18% | 175,409 | 7.46M |
| 32 | IONS | Ionis Pharmaceuticals, Inc. | 9.01B | -2.59% | 2,183,667 | 874.09M |
| 33 | PCVX | Vaxcyte, Inc. | 8.85B | 0.97% | 1,683,430 | - |
| 34 | IBRX | ImmunityBio, Inc. | 8.38B | 2.46% | 12,468,768 | 165.79M |
| 35 | SYRE | Spyre Therapeutics, Inc. | 7.99B | -0.48% | 123,092 | - |
| 36 | TWST | Twist Bioscience Corporation | 7.98B | 0.10% | 378,279 | 431.80M |
| 37 | IMVT | Immunovant, Inc. | 7.72B | -1.94% | 1,031,890 | - |
| 38 | TGTX | TG Therapeutics, Inc. | 7.64B | -2.71% | 1,368,582 | 799.54M |
| 39 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.21B | 1.76% | 123,048 | 239.92M |
| 40 | BLTE | Belite Bio, Inc | 7.00B | 1.26% | 41,957 | - |
| 41 | CAI | Caris Life Sciences, Inc. | 6.88B | 1.25% | 1,822,876 | 989.61M |
| 42 | SRRK | Scholar Rock Holding Corporation | 6.75B | -0.47% | 994,404 | - |
| 43 | CGON | CG Oncology, Inc. | 6.41B | 1.61% | 216,429 | 6.23M |
| 44 | MIRM | Mirum Pharmaceuticals, Inc. | 6.38B | -2.38% | 441,100 | 618.07M |
| 45 | TVTX | Travere Therapeutics, Inc. | 6.24B | -1.98% | 1,149,769 | 591.33M |
| 46 | ORKA | Oruka Therapeutics, Inc. | 6.12B | -0.56% | 105,952 | - |
| 47 | DNTH | Dianthus Therapeutics, Inc. | 5.94B | 2.83% | 732,764 | 1.90M |
| 48 | COGT | Cogent Biosciences, Inc. | 5.80B | -1.97% | 1,715,801 | - |
| 49 | XENE | Xenon Pharmaceuticals Inc. | 5.68B | -0.26% | 466,754 | 7.50M |
| 50 | LGND | Ligand Pharmaceuticals Incorporated | 5.67B | -1.65% | 261,165 | 290.54M |
| 51 | ERAS | Erasca, Inc. | 5.55B | -0.94% | 2,883,857 | - |
| 52 | PTCT | PTC Therapeutics, Inc. | 5.51B | -1.94% | 792,876 | 1.01B |
| 53 | DFTX | Definium Therapeutics, Inc. | 5.23B | 3.07% | 1,754,305 | - |
| 54 | CRSP | CRISPR Therapeutics AG | 5.00B | -1.03% | 856,666 | 13.39M |
| 55 | EWTX | Edgewise Therapeutics, Inc. | 4.82B | 3.50% | 1,501,972 | - |
| 56 | ACAD | ACADIA Pharmaceuticals Inc. | 4.80B | 0.32% | 1,172,681 | 1.14B |
| 57 | PBLS | Parabilis Medicines, Inc. | 4.56B | 1.54% | 364,814 | 148.00K |
| 58 | RLAY | Relay Therapeutics, Inc. | 4.14B | -0.11% | 4,164,383 | 10.35M |
| 59 | MANE | Veradermics, Incorporated | 4.13B | 0.85% | 576,017 | - |
| 60 | CELC | Celcuity Inc. | 4.08B | -2.39% | 863,368 | - |
| 61 | TNGX | Tango Therapeutics, Inc. | 4.01B | 1.75% | 2,279,286 | 53.81M |
| 62 | ELVN | Enliven Therapeutics, Inc. | 3.98B | -3.40% | 995,816 | - |
| 63 | IOVA | Iovance Biotherapeutics, Inc. | 3.90B | 5.65% | 12,388,624 | 324.97M |
| 64 | TLX | Telix Pharmaceuticals Limited | 3.82B | -5.13% | 415,334 | 890.79M |
| 65 | VKTX | Viking Therapeutics, Inc. | 3.73B | -0.47% | 2,207,193 | - |
| 66 | IDYA | IDEAYA Biosciences, Inc. | 3.63B | 0.37% | 429,248 | 234.13M |
| 67 | LEGN | Legend Biotech Corporation | 3.61B | -2.87% | 4,279,420 | 1.27B |
| 68 | ABCL | AbCellera Biologics Inc. | 3.53B | 4.11% | 4,378,318 | 66.17M |
| 69 | TARS | Tarsus Pharmaceuticals, Inc. | 3.48B | -0.51% | 75,748 | 606.33M |
| 70 | DYN | Dyne Therapeutics, Inc. | 3.40B | -1.14% | 3,774,440 | - |
| 71 | DNLI | Denali Therapeutics Inc. | 3.37B | -0.68% | 167,581 | 3.60M |
| 72 | RCUS | Arcus Biosciences, Inc. | 3.13B | -5.97% | 4,277,065 | 117.00M |
| 73 | QURE | uniQure N.V. | 3.09B | 0.09% | 1,425,283 | 18.67M |
| 74 | ARQT | Arcutis Biotherapeutics, Inc. | 3.00B | 2.16% | 2,044,715 | 463.98M |
| 75 | CLDX | Celldex Therapeutics, Inc. | 2.90B | -3.15% | 1,033,541 | 158.00K |
| 76 | MBX | MBX Biosciences, Inc. | 2.84B | -3.15% | 306,208 | - |
| 77 | IMNM | Immunome, Inc. | 2.80B | -1.20% | 692,563 | 4.02M |
| 78 | GPCR | Structure Therapeutics Inc. | 2.76B | -2.25% | 1,279,157 | - |
| 79 | ATAI | AtaiBeckley Inc. | 2.73B | - | - | 4.47M |
| 80 | NAMS | NewAmsterdam Pharma Company N.V. | 2.73B | -2.70% | 224,821 | 7.12M |
| 81 | ZLAB | Zai Lab Limited | 2.71B | -0.12% | 663,514 | 449.61M |
| 82 | IRON | Disc Medicine, Inc. | 2.69B | -5.50% | 628,946 | - |
| 83 | PHVS | Pharvaris N.V. | 2.67B | 1.36% | 1,449,491 | - |
| 84 | NRIX | Nurix Therapeutics, Inc. | 2.60B | -0.79% | 231,333 | 36.77M |
| 85 | VERA | Vera Therapeutics, Inc. | 2.53B | 4.32% | 3,796,724 | - |
| 86 | MLYS | Mineralys Therapeutics, Inc. | 2.49B | 0.14% | 84,174 | - |
| 87 | PGEN | Precigen, Inc. | 2.45B | 2.54% | 2,061,150 | 85.72M |
| 88 | HRMY | Harmony Biosciences Holdings, Inc. | 2.42B | 0.36% | 144,581 | 959.90M |
| 89 | VRDN | Viridian Therapeutics, Inc. | 2.41B | -4.71% | 944,076 | 71.13M |
| 90 | BEAM | Beam Therapeutics Inc. | 2.40B | -1.56% | 1,194,242 | 156.04M |
| 91 | NKTR | Nektar Therapeutics | 2.38B | -1.26% | 873,805 | 54.59M |
| 92 | SLS | SELLAS Life Sciences Group, Inc. | 2.33B | -14.42% | 14,709,891 | - |
| 93 | OCUL | Ocular Therapeutix, Inc. | 2.30B | -1.22% | 2,638,751 | 52.06M |
| 94 | TRVI | Trevi Therapeutics, Inc. | 2.27B | 1.45% | 896,550 | - |
| 95 | PVLA | Palvella Therapeutics, Inc. | 2.16B | -0.17% | 163,366 | - |
| 96 | SRPT | Sarepta Therapeutics, Inc. | 2.16B | -0.34% | 1,810,736 | 1.97B |
| 97 | AUPH | Aurinia Pharmaceuticals Inc. | 2.14B | -0.06% | 745,441 | 311.51M |
| 98 | NUVB | Nuvation Bio Inc. | 2.13B | -3.34% | 4,318,563 | 169.90M |
| 99 | RAPP | Rapport Therapeutics, Inc. | 2.09B | 0.37% | 251,788 | 20.00M |
| 100 | URGN | UroGen Pharma Ltd. | 2.07B | 0.17% | 698,174 | 188.73M |
| 101 | ADMA | ADMA Biologics, Inc. | 2.07B | -1.70% | 2,266,782 | 512.28M |
| 102 | KOD | Kodiak Sciences Inc. | 2.06B | 0.06% | 682,568 | - |
| 103 | ZBIO | Zenas BioPharma, Inc. | 2.03B | 0.77% | 110,060 | 1.00M |
| 104 | GENB | Generate Biomedicines, Inc. | 2.02B | 2.14% | 666,178 | 26.48M |
| 105 | AGIO | Agios Pharmaceuticals, Inc. | 2.01B | -0.12% | 750,171 | 98.34M |
| 106 | MESO | Mesoblast Limited | 2.00B | -0.45% | 27,925 | 120.25M |
| 107 | VCEL | Vericel Corporation | 1.96B | -0.84% | 60,538 | 306.30M |
| 108 | BHVN | Biohaven Ltd. | 1.92B | -0.63% | 2,863,189 | - |
| 109 | STOK | Stoke Therapeutics, Inc. | 1.87B | -1.06% | 600,715 | 27.59M |
| 110 | GHRS | GH Research PLC | 1.87B | -0.29% | 159,248 | - |
| 111 | ZYME | Zymeworks Inc. | 1.86B | -0.76% | 1,358,912 | 37.13M |
| 112 | NBTX | Nanobiotix S.A. | 1.85B | -2.47% | 33,914 | 38.27M |
| 113 | COAG | Hemab Therapeutics Holdings, Inc. | 1.84B | -1.20% | 408,085 | - |
| 114 | XNCR | Xencor, Inc. | 1.81B | 0.62% | 905,274 | 104.97M |
| 115 | KLRA | Kailera Therapeutics, Inc. | 1.81B | -6.51% | 815,442 | - |
| 116 | SEPN | Septerna, Inc. | 1.80B | 2.01% | 354,801 | 98.88M |
| 117 | VIR | Vir Biotechnology, Inc. | 1.80B | 0.38% | 2,077,968 | 303.23M |
| 118 | LKFT | Lakefront Biotherapeutics NV | 1.76B | 0.11% | 76,034 | 1.13B |
| 119 | DMRA | Damora Therapeutics, Inc. | 1.73B | 4.69% | 525,410 | - |
| 120 | KARD | Kardigan, Inc. | 1.73B | -0.91% | 416,400 | - |
| 121 | RXRX | Recursion Pharmaceuticals, Inc. | 1.72B | 1.27% | 8,034,114 | 54.86M |
| 122 | BRVE | Braveheart Bio, Inc. | 1.71B | 3.58% | 70,930 | - |
| 123 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.70B | -2.97% | 3,688,293 | 208.78M |
| 124 | IMCR | Immunocore Holdings plc | 1.68B | -1.31% | 64,354 | 430.78M |
| 125 | NTLA | Intellia Therapeutics, Inc. | 1.65B | -1.59% | 2,712,807 | 59.51M |
| 126 | FTRE | Fortrea Holdings Inc. | 1.64B | 1.06% | 1,929,704 | 2.68B |
| 127 | TSHA | Taysha Gene Therapies, Inc. | 1.64B | -2.71% | 1,777,342 | 5.49M |
| 128 | SNDX | Syndax Pharmaceuticals, Inc. | 1.62B | -3.40% | 1,223,261 | 252.25M |
| 129 | INBX | Inhibrx Biosciences, Inc. | 1.61B | -1.93% | 211,017 | 1.30M |
| 130 | ANAB | AnaptysBio, Inc. | 1.60B | -2.34% | 336,187 | 232.39M |
| 131 | NVAX | Novavax, Inc. | 1.55B | 1.29% | 6,121,466 | 413.80M |
| 132 | BCAX | Bicara Therapeutics Inc. | 1.51B | -2.08% | 43,147 | - |
| 133 | INVA | Innoviva, Inc. | 1.49B | -0.53% | 104,948 | 440.00M |
| 134 | AVLN | Avalyn Pharma Inc. | 1.49B | 0.14% | 18,203 | - |
| 135 | AAPG | Ascentage Pharma Group International | 1.47B | -3.42% | 7,144 | 94.61M |
| 136 | LTGO | Latigo Biotherapeutics, Inc. | 1.47B | 2.83% | 178,712 | - |
| 137 | LBRX | LB Pharmaceuticals Inc | 1.44B | -3.50% | 208,383 | - |
| 138 | AVBP | ArriVent BioPharma, Inc. | 1.43B | -1.15% | 46,372 | - |
| 139 | ABSI | Absci Corporation | 1.41B | -0.36% | 1,966,360 | 1.56M |
| 140 | RARE | Ultragenyx Pharmaceutical Inc. | 1.41B | -0.69% | 3,253,639 | 717.00M |
| 141 | MAZE | Maze Therapeutics, Inc. | 1.37B | -0.14% | 598,938 | 20.00M |
| 142 | SVRA | Savara Inc. | 1.35B | -0.09% | 258,554 | - |
| 143 | DRTS | Alpha Tau Medical Ltd. | 1.33B | -0.07% | 410,387 | - |
| 144 | CGEM | Cullinan Therapeutics, Inc. | 1.33B | -1.95% | 1,090,836 | - |
| 145 | OMER | Omeros Corporation | 1.32B | -1.67% | 1,014,302 | 38.42M |
| 146 | VOR | Vor Biopharma Inc. | 1.32B | -0.18% | 800,379 | - |
| 147 | TYRA | Tyra Biosciences, Inc. | 1.31B | -6.41% | 1,548,636 | - |
| 148 | TRAX | First Tracks Biotherapeutics, Inc. | 1.30B | -4.05% | 619,974 | - |
| 149 | AKTS | Aktis Oncology, Inc. | 1.30B | -2.67% | 228,578 | 10.06M |
| 150 | ANRO | Alto Neuroscience, Inc. | 1.26B | 1.01% | 415,744 | - |
| 151 | SPTX | Seaport Therapeutics, Inc. | 1.25B | 1.12% | 32,148 | - |
| 152 | ORIC | ORIC Pharmaceuticals, Inc. | 1.25B | -0.25% | 1,063,007 | - |
| 153 | MGTX | MeiraGTx Holdings plc | 1.23B | -0.47% | 459,550 | 397.50M |
| 154 | REPL | Replimune Group, Inc. | 1.22B | -2.42% | 4,085,047 | - |
| 155 | MNKD | MannKind Corporation | 1.21B | -1.06% | 2,469,875 | 393.63M |
| 156 | IMTX | Immatics N.V. | 1.20B | -1.49% | 144,528 | 47.65M |
| 157 | GLUE | Monte Rosa Therapeutics, Inc. | 1.20B | -1.75% | 1,173,894 | 28.73M |
| 158 | ALMS | Alumis Inc. | 1.19B | -7.27% | 3,424,143 | 7.40M |
| 159 | ODTX | Odyssey Therapeutics, Inc. | 1.18B | 2.88% | 31,443 | 99.00K |
| 160 | SLBT | SL Science Holding Limited | 1.17B | -1.90% | 44,429 | 3.27M |
| 161 | JBIO | Jade Biosciences, Inc. | 1.14B | -6.53% | 1,249,096 | - |
| 162 | OBX | Obsidian Therapeutics, Inc. | 1.10B | 3.73% | 392,799 | - |
| 163 | APMD | Apnimed, Inc. | 1.09B | -2.13% | 207,775 | 115.12M |
| 164 | CRVS | Corvus Pharmaceuticals, Inc. | 1.09B | -0.23% | 426,355 | - |
| 165 | MLTX | MoonLake Immunotherapeutics | 1.06B | -5.08% | 2,387,105 | - |
| 166 | JANX | Janux Therapeutics, Inc. | 1.05B | -3.28% | 791,602 | 24.00M |
| 167 | ATTO | Attovia Therapeutics, Inc. | 1.04B | 1.15% | 175,769 | 1.80M |
| 168 | KURA | Kura Oncology, Inc. | 1.01B | -1.56% | 2,117,528 | 77.23M |
| 169 | ABUS | Arbutus Biopharma Corporation | 1.01B | - | 1,850,045 | 181.72M |
| 170 | ANL | Adlai Nortye Group Ltd. | 979.49M | 0.80% | 228,743 | 18.06M |
| 171 | FTH | Faeth Therapeutics, Inc. | 967.47M | -4.00% | 377,019 | - |
| 172 | HELP | Cybin Inc. | 947.59M | 1.01% | 1,150,125 | - |
| 173 | SANA | Sana Biotechnology, Inc. | 937.00M | 1.29% | 3,280,174 | - |
| 174 | SLDB | Solid Biosciences Inc. | 932.86M | -4.08% | 1,113,837 | - |
| 175 | IVA | Inventiva S.A. | 932.40M | -2.90% | 1,713,179 | 7.94M |
| 176 | SGP | SpyGlass Pharma, Inc. | 920.49M | 0.90% | 59,722 | - |
| 177 | DSGN | Design Therapeutics, Inc. | 915.57M | -1.15% | 715,221 | - |
| 178 | WVE | Wave Life Sciences, Inc. | 904.45M | -1.71% | 2,208,377 | 65.37M |
| 179 | OLMA | Olema Pharmaceuticals, Inc. | 894.23M | -4.40% | 1,013,488 | - |
| 180 | ARDX | Ardelyx, Inc. | 892.09M | -1.10% | 5,690,239 | 450.89M |
| 181 | LXRX | Lexicon Pharmaceuticals, Inc. | 889.91M | -0.99% | 3,726,709 | 41.47M |
| 182 | TBPH | Theravance Biopharma, Inc. | 883.14M | - | 73,756 | 104.31M |
| 183 | RIGL | Rigel Pharmaceuticals, Inc. | 882.44M | -0.08% | 187,183 | 276.79M |
| 184 | IMMX | Immix Biopharma, Inc. | 868.49M | -4.41% | 1,190,506 | - |
| 185 | GERN | Geron Corporation | 867.34M | -1.46% | 14,722,266 | 204.56M |
| 186 | AVTX | Avalo Therapeutics, Inc. | 864.52M | -6.17% | 2,525,470 | 59.00K |
| 187 | CBIO | Crescent Biopharma, Inc. | 830.77M | 0.82% | 45,469 | 11.88M |
| 188 | CLYM | Climb Bio, Inc. | 818.47M | -4.68% | 1,378,431 | - |
| 189 | CADL | Candel Therapeutics, Inc. | 806.89M | -6.93% | 3,595,676 | - |
| 190 | SLN | Silence Therapeutics plc | 783.93M | -2.18% | 685,914 | 615.00K |
| 191 | ACRS | Aclaris Therapeutics, Inc. | 783.10M | -4.63% | 686,111 | 8.22M |
| 192 | NVCT | Nuvectis Pharma, Inc. | 781.63M | 6.67% | 221,084 | - |
| 193 | PHAR | Pharming Group N.V. | 761.51M | 3.70% | 39,069 | 366.48M |
| 194 | ANNX | Annexon, Inc. | 746.94M | -4.83% | 3,939,351 | - |
| 195 | MNPR | Monopar Therapeutics Inc. | 740.08M | 0.27% | 90,161 | - |
| 196 | FDMT | 4D Molecular Therapeutics, Inc. | 727.57M | -2.37% | 481,175 | 92.01M |
| 197 | ACHV | Achieve Life Sciences, Inc. | 726.49M | -3.02% | 1,461,951 | - |
| 198 | AURA | Aura Biosciences, Inc. | 725.42M | -0.93% | 254,250 | - |
| 199 | MPLT | MapLight Therapeutics, Inc. | 722.48M | -5.73% | 340,166 | - |
| 200 | DBVT | DBV Technologies S.A. | 720.55M | -8.64% | 2,699,412 | 5.04M |
| 201 | CTMX | CytomX Therapeutics, Inc. | 716.89M | -1.79% | 2,249,976 | 18.30M |
| 202 | GYRE | Gyre Therapeutics, Inc. | 713.61M | 1.34% | 17,522 | 109.82M |
| 203 | ZVRA | Zevra Therapeutics, Inc. | 713.20M | -0.41% | 583,908 | 136.07M |
| 204 | NGNE | Neurogene Inc. | 710.00M | -1.77% | 181,388 | 925.00K |
| 205 | SGMT | Sagimet Biosciences Inc. | 676.29M | -1.63% | 639,392 | - |
| 206 | MDXG | MiMedx Group, Inc. | 666.13M | -0.65% | 995,845 | 355.17M |
| 207 | PHAT | Phathom Pharmaceuticals, Inc. | 664.04M | -0.12% | 1,389,073 | 239.66M |
| 208 | VSTM | Verastem, Inc. | 662.92M | -3.94% | 1,913,863 | 87.53M |
| 209 | OCS | Oculis Holding AG | 651.89M | -6.63% | 226,616 | 1.45M |
| 210 | AGMB | AgomAb Therapeutics NV | 643.18M | -6.31% | 196,653 | - |
| 211 | BLSM | BlossomHill Therapeutics, Inc. | 639.23M | -3.02% | 148,943 | - |
| 212 | ALT | Altimmune, Inc. | 636.07M | -0.61% | 2,704,721 | 31.00K |
| 213 | VALN | Valneva SE | 635.68M | -1.20% | 25,646 | 163.30M |
| 214 | DRUG | Bright Minds Biosciences Inc. | 628.56M | -2.80% | 129,222 | - |
| 215 | STTK | Shattuck Labs, Inc. | 622.25M | 0.81% | 846,933 | 1.00M |
| 216 | ALLO | Allogene Therapeutics, Inc. | 614.97M | 1.14% | 3,894,338 | 4.64M |
| 217 | CRMD | CorMedix Inc. | 609.91M | -1.70% | 820,993 | 462.25M |
| 218 | ASMB | Assembly Biosciences, Inc. | 606.75M | -2.17% | 258,945 | 74.85M |
| 219 | OABI | OmniAb, Inc. | 591.74M | 3.04% | 1,315,827 | 38.46M |
| 220 | TECX | Tectonic Therapeutic, Inc. | 567.91M | 1.54% | 154,980 | - |
| 221 | RGNX | REGENXBIO Inc. | 563.09M | -0.35% | 1,029,133 | 174.48M |
| 222 | SCTX | Scribe Therapeutics Inc. | 563.03M | 0.92% | 141,194 | 33.30M |
| 223 | CTNM | Contineum Therapeutics, Inc. | 557.55M | 1.33% | 31,779 | - |
| 224 | PRME | Prime Medicine, Inc. | 556.84M | -6.57% | 3,077,070 | 4.07M |
| 225 | EPRX | Eupraxia Pharmaceuticals Inc. | 555.37M | 4.99% | 492,925 | - |
| 226 | ARVN | Arvinas, Inc. | 552.51M | -2.99% | 908,447 | 316.70M |
| 227 | PROK | ProKidney Corp. | 544.18M | -2.17% | 1,072,321 | 818.00K |
| 228 | OVID | Ovid Therapeutics Inc. | 525.35M | 2.28% | 1,147,532 | 1.58M |
| 229 | IRD | Opus Genetics, Inc. | 502.50M | -0.49% | 4,658,018 | 9.86M |
| 230 | AUTL | Autolus Therapeutics plc | 500.39M | -4.08% | 1,724,832 | 117.39M |
| 231 | ARTV | Artiva Biotherapeutics, Inc. | 499.66M | -1.92% | 228,437 | 251.00K |
| 232 | ZURA | Zura Bio Limited | 499.27M | -3.16% | 1,421,296 | - |
| 233 | ENTX | Entera Bio Ltd. | 491.72M | 1.79% | 187,608 | 42.00K |
| 234 | CAPR | Capricor Therapeutics, Inc. | 486.62M | 0.84% | 2,074,936 | 11.13M |
| 235 | EIKN | Eikon Therapeutics, Inc. | 484.24M | -2.93% | 1,010,238 | - |
| 236 | RLMD | Relmada Therapeutics, Inc. | 482.15M | 11.06% | 2,629,279 | - |
| 237 | SPRY | ARS Pharmaceuticals, Inc. | 473.37M | -5.93% | 2,573,537 | 116.93M |
| 238 | PRLD | Prelude Therapeutics Incorporated | 472.75M | -1.71% | 520,527 | 22.42M |
| 239 | PBYI | Puma Biotechnology, Inc. | 470.78M | -0.55% | 305,140 | 231.24M |
| 240 | CABA | Cabaletta Bio, Inc. | 462.86M | -0.36% | 7,437,306 | - |
| 241 | PRTA | Prothena Corporation plc | 458.44M | -1.66% | 77,927 | 54.53M |
| 242 | VOGX | Vogenx, Inc. | 455.24M | 2.55% | 42,028 | - |
| 243 | DNA | Ginkgo Bioworks Holdings, Inc. | 454.55M | -3.39% | 252,014 | 132.42M |
| 244 | KYTX | Kyverna Therapeutics, Inc. | 448.98M | -1.22% | 751,625 | - |
| 245 | RZLT | Rezolute, Inc. | 440.85M | 1.20% | 1,352,742 | - |
| 246 | CCCC | C4 Therapeutics, Inc. | 431.82M | 3.24% | 1,482,304 | 35.04M |
| 247 | IKT | Inhibikase Therapeutics, Inc. | 426.06M | 0.43% | 303,242 | 1.00 |
| 248 | AVIR | Atea Pharmaceuticals, Inc. | 425.89M | 2.51% | 236,566 | - |
| 249 | BNTC | Benitec Biopharma Inc. | 418.78M | 0.08% | 17,780 | - |
| 250 | ARCT | Arcturus Therapeutics Holdings Inc. | 418.67M | 5.36% | 496,634 | 29.37M |
| 251 | EDIT | Editas Medicine, Inc. | 414.67M | 1.89% | 2,463,715 | 47.01M |
| 252 | LRMR | Larimar Therapeutics, Inc. | 409.18M | 1.82% | 2,127,479 | - |
| 253 | VTVT | vTv Therapeutics Inc. | 397.22M | 0.35% | 13,724 | 36.84M |
| 254 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 396.86M | -10.33% | 1,631,027 | - |
| 255 | GALT | Galectin Therapeutics Inc. | 394.32M | 0.26% | 243,766 | - |
| 256 | FENC | Fennec Pharmaceuticals Inc. | 384.34M | -3.14% | 72,705 | 59.22M |
| 257 | EVMN | Evommune, Inc. | 382.52M | -0.24% | 74,269 | 10.00M |
| 258 | TTRX | Turn Therapeutics Inc. | 378.01M | -5.16% | 135,664 | - |
| 259 | ENTA | Enanta Pharmaceuticals, Inc. | 377.47M | -0.17% | 60,898 | 65.26M |
| 260 | INDP | Indaptus Therapeutics, Inc. | 369.08M | 8.20% | 1,802,258 | - |
| 261 | OBIO | Orchestra BioMed Holdings, Inc. | 367.84M | 5.34% | 464,460 | 31.98M |
| 262 | RCKT | Rocket Pharmaceuticals, Inc. | 367.74M | -3.74% | 1,656,847 | - |
| 263 | EYPT | EyePoint, Inc. | 364.68M | 0.71% | 767,575 | 2.79M |
| 264 | CMPX | Compass Therapeutics, Inc. | 360.18M | -2.44% | 4,828,614 | 850.00K |
| 265 | PALI | Palisade Bio, Inc. | 359.00M | 2.49% | 2,399,724 | 500.00K |
| 266 | SION | Sionna Therapeutics, Inc. | 354.92M | 3.02% | 1,210,909 | - |
| 267 | IPSC | Century Therapeutics, Inc. | 351.29M | -2.06% | 95,106 | 109.16M |
| 268 | DMAC | DiaMedica Therapeutics Inc. | 348.90M | -0.31% | 39,239 | - |
| 269 | LXEO | Lexeo Therapeutics, Inc. | 348.68M | -1.83% | 79,910 | - |
| 270 | XFOR | X4 Pharmaceuticals, Inc. | 347.01M | 2.94% | 1,252,949 | 15.85M |
| 271 | OCGN | Ocugen, Inc. | 345.89M | -0.49% | 6,471,092 | 4.58M |
| 272 | ZNTL | Zentalis Pharmaceuticals, Inc. | 332.30M | -2.23% | 787,858 | 26.87M |
| 273 | QTTB | Q32 Bio Inc. | 330.44M | 3.54% | 1,824,470 | 53.74M |
| 274 | UPB | Upstream Bio, Inc. | 313.84M | -0.87% | 85,130 | 3.16M |
| 275 | AGEN | Agenus Inc. | 312.44M | 0.73% | 790,405 | 132.69M |
| 276 | SABS | SAB Biotherapeutics, Inc. | 310.26M | -0.29% | 712,045 | 114.70K |
| 277 | ABEO | Abeona Therapeutics Inc. | 309.65M | -1.19% | 1,598,025 | 25.52M |
| 278 | IFRX | InflaRx N.V. | 308.00M | 1.95% | 334,148 | -11.54K |
| 279 | VNDA | Vanda Pharmaceuticals Inc. | 307.76M | 0.99% | 701,226 | 215.72M |
| 280 | VCRE | Vicore Pharma Holding AB (publ) | 305.08M | -6.34% | 12,889 | 412.09K |
| 281 | LYEL | Lyell Immunopharma, Inc. | 293.08M | -1.97% | 152,204 | 27.00K |
| 282 | CUVL | Clinuvel Pharmaceuticals Limited | 290.78M | 1.19% | 4,683 | 65.05M |
| 283 | FULC | Fulcrum Therapeutics, Inc. | 289.93M | - | 814,752 | 80.00M |
| 284 | YDES | YD Bio Limited | 281.28M | 2.56% | 819,273 | 510.36K |
| 285 | STRO | Sutro Biopharma, Inc. | 279.56M | -5.44% | 942,335 | 45.70M |
| 286 | FATE | Fate Therapeutics, Inc. | 276.79M | -0.86% | 742,392 | 6.49M |
| 287 | IMRX | Immuneering Corporation | 276.26M | -6.56% | 911,042 | - |
| 288 | ACIU | AC Immune SA | 274.42M | 2.60% | 105,364 | 21.67M |
| 289 | BCYC | Bicycle Therapeutics plc | 270.17M | 0.78% | 621,158 | 61.21M |
| 290 | ALXO | ALX Oncology Holdings Inc. | 268.26M | 2.11% | 1,036,362 | - |
| 291 | PYXS | Pyxis Oncology, Inc. | 267.74M | -1.83% | 1,129,486 | 11.04M |
| 292 | CAMP | Camp4 Therapeutics Corporation | 266.70M | -2.07% | 101,146 | 4.22M |
| 293 | PRQR | ProQR Therapeutics N.V. | 262.49M | -4.12% | 581,225 | 21.05M |
| 294 | FHTX | Foghorn Therapeutics Inc. | 262.48M | -1.56% | 289,027 | 36.74M |
| 295 | LCTX | Lineage Cell Therapeutics, Inc. | 255.44M | -0.98% | 913,445 | 13.08M |
| 296 | MGNX | MacroGenics, Inc. | 254.80M | 0.76% | 381,932 | 175.14M |
| 297 | RNAC | Cartesian Therapeutics, Inc. | 247.79M | -2.85% | 123,127 | 1.48M |
| 298 | TRDA | Entrada Therapeutics, Inc. | 245.19M | 5.92% | 291,808 | 4.69M |
| 299 | AVXL | Anavex Life Sciences Corp. | 242.87M | 2.07% | 107,965 | - |
| 300 | ALEC | Alector, Inc. | 238.95M | - | 4,699,046 | 13.86M |
| 301 | NGEN | NervGen Pharma Corp. | 234.94M | 1.16% | 559,044 | - |
| 302 | WHWK | Whitehawk Therapeutics, Inc. | 234.31M | 0.98% | 283,519 | 7.15M |
| 303 | CGEN | Compugen Ltd. | 233.97M | 0.41% | 46,006 | 74.00M |
| 304 | VRXA | Veraxa Biotech AG | 233.32M | - | 88,877 | 29.54K |
| 305 | IVVD | Invivyd, Inc. | 231.53M | 1.24% | 4,384,924 | 58.37M |
| 306 | ADAG | Adagene Inc. | 228.29M | 2.72% | 258,866 | 9.29M |
| 307 | YARW | Yarrow Bioscience, Inc. | 227.94M | -5.03% | 1,364,922 | - |
| 308 | GLSI | Greenwich LifeSciences, Inc. | 226.78M | 2.59% | 75,002 | - |
| 309 | ELDN | Eledon Pharmaceuticals, Inc. | 226.13M | - | 638,398 | - |
| 310 | TARA | Protara Therapeutics, Inc. | 225.74M | 0.79% | 532,026 | - |
| 311 | SRZN | Surrozen, Inc. | 223.32M | -0.23% | 23,591 | 11.51M |
| 312 | CLLS | Cellectis S.A. | 222.25M | -1.28% | 16,993 | 63.82M |
| 313 | KROS | Keros Therapeutics, Inc. | 219.69M | -0.09% | 21,071 | 15.01M |
| 314 | SLGL | Sol-Gel Technologies Ltd. | 215.89M | -1.27% | 24,997 | 1.80M |
| 315 | PLX | Protalix BioTherapeutics, Inc. | 212.71M | -3.30% | 646,807 | 80.62M |
| 316 | ABOS | Acumen Pharmaceuticals, Inc. | 211.17M | 2.10% | 318,276 | - |
| 317 | CUE | Cue Biopharma, Inc. | 208.78M | 2.64% | 122,768 | 37.66M |
| 318 | NKTX | Nkarta, Inc. | 208.43M | 3.56% | 487,412 | - |
| 319 | PEPG | PepGen Inc. | 206.39M | -1.32% | 683,010 | - |
| 320 | CHRS | Coherus Oncology, Inc. | 205.49M | -0.75% | 529,193 | 50.94M |
| 321 | ANTX | AN2 Therapeutics, Inc. | 204.15M | -4.92% | 103,538 | - |
| 322 | TNXP | Tonix Pharmaceuticals Holding Corp. | 203.58M | -3.34% | 513,434 | 29.10M |
| 323 | KRRO | Korro Bio, Inc. | 203.36M | 5.74% | 197,974 | 2.38M |
| 324 | MSLE | Satellos Bioscience Inc. | 201.88M | 1.64% | 7,520 | - |
| 325 | ARMP | Armata Pharmaceuticals, Inc. | 200.04M | 2.87% | 43,627 | 5.54M |
| 326 | NERV | Minerva Neurosciences, Inc. | 198.15M | 3.43% | 15,934 | - |
| 327 | DTIL | Precision BioSciences, Inc. | 197.90M | -1.67% | 44,046 | 45.06M |
| 328 | VYGR | Voyager Therapeutics, Inc. | 196.56M | - | 276,063 | 34.46M |
| 329 | NMRA | Neumora Therapeutics, Inc. | 195.41M | -8.77% | 1,880,830 | - |
| 330 | ORMP | Oramed Pharmaceuticals Inc. | 193.84M | -2.10% | 144,534 | 2.00M |
| 331 | ACOG | Alpha Cognition Inc. | 193.82M | - | 85,337 | 15.26M |
| 332 | NBP | NovaBridge Biosciences | 184.44M | -5.92% | 252,832 | - |
| 333 | RNA | Atrium Therapeutics, Inc. | 177.21M | 0.10% | 247,499 | 35.84M |
| 334 | IPHA | Innate Pharma S.A. | 173.11M | 1.07% | 2,878 | 10.57M |
| 335 | MDWD | MediWound Ltd. | 169.25M | -2.26% | 8,127 | 11.86M |
| 336 | CNTN | Canton Strategic Holdings, Inc. | 168.13M | -1.86% | 758,870 | 1.50M |
| 337 | OTLK | Outlook Therapeutics, Inc. | 160.68M | -0.18% | 3,334,025 | -1.16M |
| 338 | CDXS | Codexis, Inc. | 160.43M | 1.74% | 505,054 | 77.68M |
| 339 | HUMA | Humacyte, Inc. | 157.68M | 0.09% | 2,264,995 | 2.12M |
| 340 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 157.05M | -1.46% | 2,347,744 | - |
| 341 | MOLN | Molecular Partners AG | 156.35M | -0.71% | 61 | 856.30K |
| 342 | IMUX | Immunic, Inc. | 155.82M | -3.55% | 332,732 | - |
| 343 | SPRB | Spruce Biosciences, Inc. | 154.33M | -1.20% | 88,507 | 697.00K |
| 344 | KZIA | Kazia Therapeutics Limited | 153.34M | 1.63% | 340,791 | 1.27M |
| 345 | MENS | Jyong Biotech Ltd. | 147.72M | -1.00% | 45,354 | - |
| 346 | UNCY | Unicycive Therapeutics, Inc. | 147.35M | -0.38% | 1,116,676 | - |
| 347 | NRXP | NRx Pharmaceuticals, Inc. | 147.09M | - | 356,231 | 3.39M |
| 348 | TNYA | Tenaya Therapeutics, Inc. | 143.51M | -1.36% | 1,375,182 | 1.34M |
| 349 | LENZ | LENZ Therapeutics, Inc. | 142.02M | -4.24% | 978,153 | 21.48M |
| 350 | MIST | Milestone Pharmaceuticals Inc. | 138.11M | -6.66% | 3,323,791 | 2.34M |
| 351 | CRBU | Caribou Biosciences, Inc. | 136.15M | -7.30% | 2,432,287 | 10.04M |
| 352 | EQ | Equillium, Inc. | 133.79M | -12.81% | 554,043 | 4.39M |
| 353 | HURA | TuHURA Biosciences, Inc. | 130.64M | 0.99% | 113,969 | - |
| 354 | NAUT | Nautilus Biotechnology, Inc. | 129.80M | 3.07% | 826,871 | 190.00K |
| 355 | INO | Inovio Pharmaceuticals, Inc. | 129.25M | -2.34% | 2,392,904 | 65.34K |
| 356 | CNTB | Connect Biopharma Holdings Limited | 128.47M | -0.97% | 878,040 | 2.95M |
| 357 | BMEA | Biomea Fusion, Inc. | 126.12M | 2.35% | 1,481,264 | - |
| 358 | OKUR | OnKure Therapeutics, Inc. | 125.54M | -1.83% | 29,613 | - |
| 359 | TLSA | Tiziana Life Sciences Ltd | 124.14M | -0.41% | 277,705 | - |
| 360 | PMN | ProMIS Neurosciences, Inc. | 121.60M | -2.61% | 6,288 | - |
| 361 | ENGN | enGene Therapeutics Inc. | 120.58M | 1.69% | 651,007 | - |
| 362 | CBUS | Cibus, Inc. | 119.99M | -0.95% | 83,961 | 4.35M |
| 363 | CNXU | Conexeu Sciences Inc. | 119.34M | 4.94% | 114,214 | - |
| 364 | RANI | Rani Therapeutics Holdings, Inc. | 117.45M | 2.51% | 312,325 | 4.88M |
| 365 | VANI | Vivani Medical, Inc. | 114.56M | 1.60% | 249,366 | - |
| 366 | BDTX | Black Diamond Therapeutics, Inc. | 113.76M | 1.02% | 590,205 | 70.00M |
| 367 | AARD | Aardvark Therapeutics, Inc. | 112.27M | 5.49% | 130,887 | - |
| 368 | GNLX | Genelux Corporation | 111.58M | 0.40% | 146,907 | 8.00K |
| 369 | SEER | Seer, Inc. | 107.98M | 0.78% | 21,506 | 14.22M |
| 370 | TENX | Tenax Therapeutics, Inc. | 106.54M | -4.62% | 2,724,582 | - |
| 371 | PMVP | PMV Pharmaceuticals, Inc. | 105.72M | -2.78% | 539,350 | - |
| 372 | PYPD | PolyPid Ltd. | 104.61M | -0.19% | 100,183 | - |
| 373 | COYA | Coya Therapeutics, Inc. | 102.75M | -1.34% | 39,055 | 8.02M |
| 374 | ACET | Adicet Bio, Inc. | 102.48M | -0.10% | 119,504 | - |
| 375 | GUTS | Fractyl Health, Inc. | 101.88M | -0.48% | 751,821 | 3.00K |
| 376 | PLYX | Polaryx Therapeutics, Inc. | 100.19M | 1.01% | 14,523 | - |
| 377 | ONCY | Oncolytics Biotech Inc. | 95.06M | -3.43% | 1,203,783 | - |
| 378 | ATRA | Atara Biotherapeutics, Inc. | 94.15M | -5.16% | 16,034 | 6.19M |
| 379 | CRDF | Cardiff Oncology, Inc. | 94.13M | - | 493,354 | 508.00K |
| 380 | ANIX | Anixa Biosciences, Inc. | 93.90M | 0.36% | 389,350 | - |
| 381 | CGTX | Cognition Therapeutics, Inc. | 93.46M | 0.32% | 218,016 | - |
| 382 | NTHI | NeOnc Technologies Holdings, Inc. | 91.47M | 0.55% | 188,718 | 39.99K |
| 383 | RLYB | Rallybio Corporation | 89.61M | 0.75% | 6,627 | 646.00K |
| 384 | ICCC | ImmuCell Corporation | 89.46M | -0.76% | 3,531 | 30.68M |
| 385 | MNOV | MediciNova, Inc. | 89.09M | 4.02% | 45,965 | 920.48K |
| 386 | ACRV | Acrivon Therapeutics, Inc. | 85.71M | -3.43% | 64,434 | - |
| 387 | NTRB | Nutriband Inc. | 84.60M | 14.47% | 99,813 | 1.62M |
| 388 | VRCA | Verrica Pharmaceuticals Inc. | 84.35M | -0.81% | 41,892 | 30.32M |
| 389 | FBIO | Fortress Biotech, Inc. | 84.04M | -1.95% | 209,700 | 68.47M |
| 390 | PTHS | Pelthos Therapeutics Inc. | 83.84M | -2.36% | 18,947 | 43.30M |
| 391 | ALDX | Aldeyra Therapeutics, Inc. | 80.84M | -8.22% | 1,565,518 | - |
| 392 | TELO | Telomir Pharmaceuticals, Inc. | 80.47M | -0.85% | 33,259 | - |
| 393 | KLRS | Kalaris Therapeutics, Inc. | 80.46M | 2.42% | 95,102 | - |
| 394 | RNXT | RenovoRx, Inc. | 79.43M | -0.56% | 1,167,878 | 1.98M |
| 395 | MAIA | MAIA Biotechnology, Inc. | 79.07M | -0.76% | 678,026 | - |
| 396 | OSTX | OS Therapies Incorporated | 77.49M | -7.69% | 825,503 | - |
| 397 | IBIO | iBio, Inc. | 77.49M | -1.63% | 184,893 | 100.00K |
| 398 | BSEM | BioStem Technologies, Inc. | 76.93M | 3.23% | 143,079 | 34.59M |
| 399 | GANX | Gain Therapeutics, Inc. | 76.38M | 2.34% | 223,494 | - |
| 400 | OKYO | OKYO Pharma Limited | 73.47M | 1.45% | 1,104 | - |
| 401 | CING | Cingulate Inc. | 73.00M | -2.90% | 99,571 | - |
| 402 | ATHE | Alterity Therapeutics Limited | 72.81M | 2.43% | 10,036 | 2.50M |
| 403 | PLRX | Pliant Therapeutics, Inc. | 72.45M | 3.54% | 173,460 | - |
| 404 | NRXS | NeurAxis, Inc. | 72.08M | 0.88% | 46,311 | 5.32M |
| 405 | CSBR | Champions Oncology, Inc. | 70.86M | - | 10,113 | 60.66M |
| 406 | RNTX | Rein Therapeutics Inc. | 67.72M | 0.53% | 295,565 | - |
| 407 | XBIT | XBiotech Inc. | 66.77M | 0.46% | 4,869 | - |
| 408 | ALPS | Alps Group Inc | 66.56M | 3.92% | 139,824 | 3.74M |
| 409 | DWTX | Dogwood Therapeutics, Inc. | 65.95M | 3.19% | 53,084 | - |
| 410 | SPRO | Spero Therapeutics, Inc. | 65.81M | 0.89% | 310,631 | 47.00M |
| 411 | GOSS | Gossamer Bio, Inc. | 65.57M | -5.79% | 474,132 | 53.29M |
| 412 | LONA | LeonaBio, Inc. | 65.20M | 0.87% | 42,677 | - |
| 413 | BOLD | Boundless Bio, Inc. | 64.37M | -0.70% | 40,011 | - |
| 414 | ELOX | Eloxx Pharmaceuticals, Inc. | 63.57M | -3.26% | 17,169 | - |
| 415 | INMB | INmune Bio Inc. | 61.61M | -3.90% | 228,375 | 50.00K |
| 416 | HYFT | MindWalk Holdings Corp. | 61.32M | -1.14% | 74,725 | 11.43M |
| 417 | INKT | MiNK Therapeutics, Inc. | 61.24M | -1.07% | 42,354 | - |
| 418 | HRTX | Heron Therapeutics, Inc. | 59.90M | -2.11% | 1,371,704 | 151.18M |
| 419 | IMMP | Immutep Limited | 59.19M | 14.83% | 3,207,268 | 13.79M |
| 420 | XLO | Xilio Therapeutics, Inc. | 58.76M | - | 5,147 | 64.09M |
| 421 | EXOZ | eXoZymes, Inc. | 58.49M | 2.13% | 4,559 | -700.00 |
| 422 | IMA | ImageneBio, Inc. | 57.67M | 1.40% | 8,047 | 800.00K |
| 423 | EDSA | Edesa Biotech, Inc. | 57.15M | -9.23% | 26,794 | - |
| 424 | SER | Serina Therapeutics, Inc. | 56.39M | -11.20% | 69,308 | 130.00K |
| 425 | HYPD | Hyperion DeFi, Inc. | 54.23M | -2.79% | 500,377 | 1.40M |
| 426 | ELTX | Elicio Therapeutics, Inc. | 53.88M | -2.84% | 445,751 | - |
| 427 | APLM | Apollomics, Inc. | 50.96M | -2.75% | 5,852 | 8.84M |
| 428 | TIL | Instil Bio, Inc. | 50.05M | -0.54% | 611 | - |
| 429 | MCRB | Seres Therapeutics, Inc. | 49.81M | 0.78% | 9,533 | 1.88M |
| 430 | IBO | Impact BioMedical Inc. | 49.62M | 4.35% | 310,591 | 35.00K |
| 431 | TVGN | Tevogen Inc. | 47.92M | 0.96% | 72,674 | - |
| 432 | HOWL | Werewolf Therapeutics, Inc. | 47.72M | -0.66% | 549,195 | 21.00M |
| 433 | ANVS | Annovis Bio, Inc. | 47.72M | -5.88% | 1,894,431 | - |
| 434 | GRCE | Grace Therapeutics, Inc. | 46.70M | -1.77% | 716,523 | - |
| 435 | MREO | Mereo BioPharma Group plc | 44.71M | 14.47% | 5,109,940 | 500.00K |
| 436 | ATNM | Actinium Pharmaceuticals, Inc. | 44.02M | 6.87% | 242,659 | 35.09M |
| 437 | MGX | Metagenomi Therapeutics, Inc. | 43.82M | - | 54,277 | 13.56M |
| 438 | ATYR | aTyr Pharma, Inc. | 42.16M | -0.49% | 1,425,365 | 190.00K |
| 439 | VERU | Veru Inc. | 41.60M | -2.40% | 245,308 | 16.89M |
| 440 | CELU | Celularity Inc. | 40.81M | -1.74% | 97,105 | 26.55M |
| 441 | CRVO | CervoMed Inc. | 38.86M | 3.63% | 234,572 | 331.30K |
| 442 | LITS | Lite Strategy, Inc. | 37.77M | 4.72% | 137,181 | - |
| 443 | FLNA | Filana Therapeutics, Inc. | 37.32M | -4.49% | 309,553 | - |
| 444 | KPTI | Karyopharm Therapeutics Inc. | 36.52M | -0.62% | 6,737,667 | 146.62M |
| 445 | ALGS | Aligos Therapeutics, Inc. | 32.60M | -2.06% | 37,043 | 31.52M |
| 446 | KYNB | Kyntra Bio, Inc. | 32.27M | -0.13% | 9,683 | 4.62M |
| 447 | CNTX | Context Therapeutics Inc. | 32.19M | -4.37% | 829,842 | - |
| 448 | NXTC | NextCure, Inc. | 32.04M | -4.24% | 115,759 | - |
| 449 | BCTX | BriaCell Therapeutics Corp. | 31.61M | 0.83% | 74,714 | - |
| 450 | BYSI | BeyondSpring Inc. | 31.42M | -0.37% | 95,085 | 1.88M |
| 451 | QNCX | Quince Therapeutics, Inc. | 30.05M | 2.04% | 2,003 | - |
| 452 | IGC | IGC Pharma, Inc. | 28.80M | -1.55% | 415,678 | 1.11M |
| 453 | ESLA | Estrella Immunopharma, Inc. | 28.69M | -1.99% | 25,929 | - |
| 454 | RNAZ | TransCode Therapeutics, Inc. | 28.61M | - | 11,445 | - |
| 455 | CVM | CEL-SCI Corporation | 26.21M | -1.97% | 98,521 | - |
| 456 | EVAX | Evaxion A/S | 26.10M | 0.97% | 30,259 | 7.49M |
| 457 | QNTM | Quantum BioPharma Ltd. | 25.88M | -2.74% | 200,775 | - |
| 458 | ACTU | Actuate Therapeutics, Inc. | 25.70M | -6.96% | 239,600 | - |
| 459 | ABVC | ABVC BioPharma, Inc. | 25.41M | 0.40% | 97,633 | 797.92K |
| 460 | ATOS | Atossa Therapeutics, Inc. | 25.05M | 7.26% | 60,410 | - |
| 461 | TVRD | Tvardi Therapeutics, Inc. | 24.94M | 1.91% | 116,425 | - |
| 462 | RADX | Radiopharm Theranostics Limited | 24.89M | -3.88% | 37,601 | 9.34M |
| 463 | COCP | Cocrystal Pharma, Inc. | 23.89M | 0.81% | 58,539 | 330.00K |
| 464 | LGVN | Longeveron Inc. | 23.37M | 10.39% | 68,125 | 1.19M |
| 465 | NNVC | NanoViricides, Inc. | 23.24M | - | 286,637 | - |
| 466 | PLRZ | Polyrizon Ltd. | 23.21M | 1.02% | 569 | - |
| 467 | AKTX | Akari Therapeutics, Plc | 22.00M | 3.86% | 135,176 | - |
| 468 | JSPR | Jasper Therapeutics, Inc. | 21.97M | -5.77% | 294,293 | - |
| 469 | LTRN | Lantern Pharma Inc. | 21.86M | -2.84% | 109,811 | - |
| 470 | CLRB | Cellectar Biosciences, Inc. | 21.83M | -2.53% | 38,345 | - |
| 471 | TCRX | TScan Therapeutics, Inc. | 21.72M | 0.79% | 873,124 | 7.11M |
| 472 | PTN | Palatin Technologies, Inc. | 21.07M | -0.25% | 14,794 | 12.88M |
| 473 | PBM | Psyence Biomedical Ltd. | 20.60M | 8.65% | 134,486 | - |
| 474 | GRDX | GridAI Technologies Corp. | 20.25M | -3.70% | 134,163 | - |
| 475 | NEUP | Neuphoria Therapeutics Inc. | 20.16M | 0.27% | 16,560 | -13.27K |
| 476 | ALLR | Allarity Therapeutics, Inc. | 19.41M | -2.40% | 210,232 | 345.00K |
| 477 | MRKR | Marker Therapeutics, Inc. | 19.17M | -4.17% | 59,368 | 3.55M |
| 478 | NCEL | NewcelX Ltd. | 19.09M | -2.23% | 3,750 | - |
| 479 | LPCN | Lipocine Inc. | 18.71M | 1.30% | 1,517 | 1.57M |
| 480 | CMMB | Chemomab Therapeutics Ltd. | 18.69M | -0.77% | 101,350 | - |
| 481 | KTTA | Pasithea Therapeutics Corp. | 17.71M | -1.85% | 141,691 | - |
| 482 | CNSY | Cerenome, Inc. | 17.65M | -2.72% | 79,988 | 4.20M |
| 483 | DYAI | Dyadic International, Inc. | 17.64M | -1.18% | 148,459 | 3.80M |
| 484 | NIKI | Niki BioSolutions, Inc. | 16.78M | -8.35% | 37,082 | - |
| 485 | ENLV | Enlivex Ltd. | 16.78M | -2.16% | 255,974 | - |
| 486 | PDSB | PDS Biotechnology Corporation | 16.51M | -6.47% | 5,839,190 | - |
| 487 | BCDA | BioCardia, Inc. | 16.35M | -1.82% | 137,031 | 3.00K |
| 488 | AEON | AEON Biopharma, Inc. | 16.31M | 12.72% | 31,010,519 | - |
| 489 | PASG | Passage Bio, Inc. | 16.09M | 0.30% | 7,890 | - |
| 490 | CTXR | Citius Pharmaceuticals, Inc. | 15.95M | -0.73% | 155,627 | 7.11M |
| 491 | GTBP | GT Biopharma, Inc. | 15.54M | 39.32% | 544,275 | - |
| 492 | LSTA | Lisata Therapeutics, Inc. | 14.69M | -0.61% | 111,886 | 100.00K |
| 493 | MLEC | Moolec Science SA | 14.62M | -4.87% | 102,015 | 7.83M |
| 494 | PLUR | Pluri Inc. | 14.57M | -5.60% | 9,629 | 1.02M |
| 495 | BIVI | BioVie Inc. | 14.56M | 1.05% | 170,760 | - |
| 496 | HIND | Vyome Holdings, Inc. | 14.46M | -1.90% | 17,529 | 129.73K |
| 497 | MBRX | Moleculin Biotech, Inc. | 13.93M | -13.85% | 1,931,958 | - |
| 498 | QNRX | Quoin Pharmaceuticals, Ltd. | 13.64M | -1.59% | 65,673 | - |
| 499 | CALC | CalciMedica, Inc. | 13.52M | -6.60% | 23,152 | - |
| 500 | ICU | SeaStar Medical Holding Corporation | 13.35M | -3.19% | 44,996 | 1.71M |